ELI LILLY & Co - 23 Jul 2026 Form 3 Insider Report for Scribe Therapeutics, Inc. (SCTX)

Reporting relationship: 10%+ Owner
Issuer ticker: SCTX
Reported as of: 23 Jul 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 23 Jul 2026, 21:45:03 UTC
Prior SEC filing: 15 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary

Key filing fact

ELI LILLY & Co filed Form 3 for Scribe Therapeutics, Inc. (SCTX) on 23 Jul 2026.

Key facts

This page summarizes ELI LILLY & Co's Form 3 filing for Scribe Therapeutics, Inc. (SCTX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 23 Jul 2026, 21:45.

Change

Previous filing in this sequence was filed on 15 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0000059478 Primary reporting owner

ELI LILLY & Co

Relationship: 10%+ Owner
Address: LILLY CORPORATE CENTER, INDIANAPOLIS
Signature: /s/ Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
Signature date: 23 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SCTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,054,828
Date: 23 Jul 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

After giving effect to closing of the Issuer's initial public offering, the Reporting Person will cease to be a 10% Owner and, accordingly, will have no further Section 16 reporting obligations.